ARCHIVES

In Brief: Phil Amoruso Will Be The New NCI Executive Officer; DRCCA Board Okays CCN Extension

This article is from The Cancer Letter archive.

Vol. 07 No. 01 | January 2, 1981

Download PDF Visit The Full Archive

Related Articles

Erbitux Addition to Chemotherapy Regimen Can Make Inoperable Disease Operable

April 26, 2013

NCI’s SBIR Awards Move Up In Quality; Congress considers Making It Permanent; FASEB Object

September 19, 1986

NCI STRAP Grants Aim To Move Research Quickly To Clinical Trials

October 1, 2010

UPCI Clarifies Agreement Between Eli Lilly And PCRN.

July 27, 2001

Group Backing Epstein Received Grants From Reynolds Foundation

May 15, 1992

NCI, Groups Disagree Over Recovery Of Funds In Cases of Scientific Fraud

October 7, 1994